A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.
about
Periocular corticosteroid injections in uveitis: effects and complications.Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.Corneal lymphangiogenesis in herpetic stromal keratitisLocal therapies for inflammatory eye disease in translation: past, present and futureHybrid Electrospun Polycaprolactone Mats Consisting of Nanofibers and Microbeads for Extended Release of Dexamethasone.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.Modeling intraocular bacterial infections.Therapeutic effect of melatonin in experimental uveitis.Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.Reply to: Costa DC et al. The use of subconjunctival triamcinolone acetonide (SCTA) in the management of corneal endothelial graft rejection.AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.[DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].Controlled release of betamethasone from vitamin E-loaded silicone-based soft contact lenses.The effect of silicone hydrogel contact lens composition on dexamethasone release.
P2860
Q34624389-6C9C363A-A2A3-4DAB-91A9-9A54E24E1DEEQ34657063-2804D58E-4C06-4866-9467-3D1F092D3293Q34674612-EE94CE4B-CB1C-4FB7-B233-8F72BB3925F5Q34892662-12F9B7BB-3F83-40DD-AF68-CB4A8AE156ECQ35956598-850B49C5-820E-4403-980A-8655ED55F54DQ37769529-43ABDF2E-5800-4072-B497-3F56C65F8177Q37956187-B6F9762C-A447-4B9F-9715-4D21A8AD090FQ37992705-D70E4A69-CBFF-4920-8A44-A0DC440BCA41Q38168361-A9B053E5-D608-4CB7-A29F-F7204AA1315AQ38172584-B9F630DD-4A56-4DDC-A6AC-8789FBD213BEQ38827899-E26E65D2-7B93-4FA9-87B8-E4B276A3F363Q41895570-8437A978-9466-4925-A0C9-6BF2EB2251C6Q43601228-E315A0C8-9E1E-4BD8-A48E-5A744D8F9AA4Q46189073-D0AA5EF1-2EE1-439A-94F4-0B0022DA928EQ49037118-DECE10C1-EE81-4884-9394-23B451141F0AQ49845401-B94F1717-625F-40C7-BD8A-87B262897DA0Q51785933-80741AB8-E93F-4A1D-AEDA-353A8C5D2DC7Q53616759-EB76C238-DD09-4820-BB0E-F1EA5CCD659D
P2860
A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A review of evidence guiding t ...... t of intraocular inflammation.
@ast
A review of evidence guiding t ...... t of intraocular inflammation.
@en
type
label
A review of evidence guiding t ...... t of intraocular inflammation.
@ast
A review of evidence guiding t ...... t of intraocular inflammation.
@en
prefLabel
A review of evidence guiding t ...... t of intraocular inflammation.
@ast
A review of evidence guiding t ...... t of intraocular inflammation.
@en
P2860
P356
P1476
A review of evidence guiding t ...... t of intraocular inflammation.
@en
P2093
Paul A Gaudio
P2860
P304
P356
10.1080/092739490500192
P577
2004-09-01T00:00:00Z